Cubist Systematic Strategies, LLC Allogene Therapeutics, Inc. Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$2.28 - $3.5 $300,048 - $460,600	-131,600 Reduced 61.45%	82,544 $264,000
Q3 2023 Nov 14, 2023	BUY	$3.17 - $5.96 $615,743 - $1.16 Million	194,241 Added 975.94%	214,144 $678,000
Q2 2023 Aug 14, 2023	SELL	$4.53 - $6.74 $2.05 Million - $3.05 Million	-452,739 Reduced 95.79%	19,903 $98,000
Q1 2023 May 15, 2023	BUY	$4.92 - $8.21 $903,523 - $1.51 Million	183,643 Added 63.54%	472,642 $2.33 Million
Q4 2022 Feb 14, 2023	SELL	$5.62 - $11.11 $1.63 Million - $3.22 Million	-290,246 Reduced 50.11%	288,999 $1.82 Million
Q3 2022 Nov 14, 2022	BUY	$10.32 - $17.28 $3.14 Million - $5.26 Million	304,445 Added 110.79%	579,245 $6.26 Million
Q2 2022 Aug 15, 2022	BUY	$6.78 - $12.28 $466,240 - $844,458	68,767 Added 33.38%	274,800 $3.13 Million
Q1 2022 May 16, 2022	BUY	$7.65 - $15.29 $499,108 - $997,565	65,243 Added 46.34%	206,033 $1.88 Million
Q4 2021 Feb 14, 2022	BUY	$13.13 - $24.52 $1.85 Million - $3.45 Million	140,790 New	140,790 $2.1 Million
Q3 2021 Nov 15, 2021	SELL	$21.01 - $27.64 $2.62 Million - $3.44 Million	-124,598 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$23.49 - $35.8 $2.27 Million - $3.45 Million	96,497 Added 343.39%	124,598 $3.25 Million
Q1 2021 May 17, 2021	SELL	$25.79 - $39.02 $2.17 Million - $3.29 Million	-84,220 Reduced 74.98%	28,101 $992,000
Q4 2020 Feb 16, 2021	BUY	$25.24 - $43.45 $2.83 Million - $4.88 Million	112,321 New	112,321 $2.84 Million
Q3 2020 Nov 16, 2020	SELL	$32.38 - $44.96 $386,714 - $536,957	-11,943 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$18.39 - $54.04 $38,048 - $111,808	-2,069 Reduced 14.77%	11,943 $511,000
Q1 2020 May 15, 2020	SELL	$18.22 - $28.25 $452,238 - $701,193	-24,821 Reduced 63.92%	14,012 $272,000
Q4 2019 Feb 14, 2020	BUY	$24.82 - $31.4 $963,835 - $1.22 Million	38,833 New	38,833 $1.01 Million

Others Institutions Holding ALLO

# of Institutions

163

Shares Held

134M

Call Options Held

59.4K

Put Options Held

113K

View Full List

About Allogene Therapeutics, Inc.

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $262M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

More about ALLO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account